期刊文献+

TRAF6基因RNA干涉表达载体的构建及鉴定 被引量:2

Construction and identification of siRNA against tumor necrosis factor receptor associated factor 6 (TRAF6)
下载PDF
导出
摘要 目的构建针对小鼠肿瘤坏死因子受体相关因子6(TRAF6)的mRNA的siRNA真核表达载体,并鉴定其正确性。方法利用基因重组技术,化学合成用于产生针对TRAF6的发卡状RNA的寡核苷酸,各64个碱基,退火后插入线性化的pSUPER载体的H1启动子下游。重组载体分别用限制性酶切和测序鉴定其正确性。结果限制性酶切和序列测定表明成功构建了可以表达针对TRAF6的发卡状RNA表达载体。结论成功构建了针对TRAF6的发卡状RNA表达载体,为研究TRAF6的功能和进一步的基因治疗提供了实验基础。 Objective To construct and identify vectors expressing siRNA against tumor necrosis factor receptor associated factor 6 (TRAF6). Methods Using gene recombination techniques, 64-bp oligonucleotidcs for hairpin RNA targeting TRAF6 were synthesized, annealed, and inserted into the downstream of H1 promoter of linearized pSUPER to form recombinant vectors, which were identified by restriction digestion and DNA sequencing. Results Restriction digestion and DNA sequencing showed suecessihl construction of TRAF6-targeting siRNA. Conclusion Vectors ex- pressing hairpin RNA against TRAF6 were successfully produced, which would facilitate further studies of TRAF6 function and its use in geuotherapy.
出处 《中国药物与临床》 CAS 2007年第7期502-504,共3页 Chinese Remedies & Clinics
基金 国家自然科学基金资助项目(30271418) 山西省青年科技开发基金资助项目(2006021041)
关键词 受体 肿瘤坏死因子 基因表达 遗传载体 Receptors, tumor necrosis factor Gene expression Genetic vectors
  • 相关文献

参考文献6

  • 1Poubelle PE,Chakravarti A,Femandes MJ,et al.Differential expression of RANK/RANK-L/OPG by synovial fluid neutrophils from patients with rheumatoid arthritis and normal human blood neutrophils.Arthritis Res Ther,2007,9(2):R25-37.
  • 2Ait-Si-AIi S,Guaseoni V,Hard BA.RNA interference and its possible use in cancer therapy.Bull Cancer,2004,91:15-18.
  • 3McManus MT,Sharp PA.Gene silencing in mammals by small interfering RNAs.Nat Rev Genet,2002,3:737-747.
  • 4Brummelkamp TR,Bemards R,Agami B.A system for stable expression of shoa interfering RNAs in mammalian cells.Science,2002,296:550-553.
  • 5Jeong S,Cho IR,An WG,et al.STP-All,an oncoprotein of Herpesvirus saimiri augments both NF-kappaB and AP-1 transcription activity through TRAF6.Exp Mol Med,2007,39:56-64.
  • 6Mercier P,Lewis MJ,Hau DD,et al.Structure,interactions,and dynamics of the RING domain from human rmAF6.Protein Sci,2007,16:602-614.

同被引文献24

  • 1李霞,肖明振,余擎,赵守亮,郭婷,高杰,吕昕,何文喜.肿瘤坏死因子受体相关分子6在成牙本质细胞中表达的研究[J].临床口腔医学杂志,2005,21(3):143-145. 被引量:4
  • 2Ichikawa D, Funakoshi-Tago M, Aizu-Yokota E, et al. TNF-re- ceptor associated factor 6-deficient fibroblast is sensitive to the TNF-alpha-induced cell death : involvement of reactive oxygen spe- cies [ J ]. Biochem Biophys Res Commun,2006, 351 ( 1 ) :93 - 8.
  • 3Zapata J M, Lefebvre S, Reed J C. Targeting TRAFs for therapeutic intervention[ J]. Adv Exp Med Biol,2007,597 : 188 - 201.
  • 4Lu L F,Ahonen C L,Lind E F,et al. The in vivo function of a non- canonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiation [ J ]. Blood, 2007, 110 (1) :193 -200.
  • 5Pineda G, Ea C K. Chen Z J. Ubiquitination and TRAF signaling [ J]. Adv Exp Med Biol,2007,597:80 - 92.
  • 6Rowland S L, Tremblay M M, Ellison J M, et al. A novel mecha- nism for TNFR-associated factor 6-dependent CD40 signaling[ J ]. Immunol,2007,179 ( 7 ) :4645 - 53.
  • 7Maezawa Y, Nakajima H, Suzuki K, et al. Involvement of TNF re- ceptor-associated factor 6 in IL-25 receptor signaling [ J ]. Immu- nol,2006,176(2) :1013 -8.
  • 8Bonif M, Meuwis M A, Close P, et al. TNF-α and IKKβ-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKγ and NF-κB activation [J]. Biochem J, 2006,394 (Pt3) :593 -603.
  • 9Yang Y J, Chen W, Carrigan S O, et al. TRAF6 specifically con- tributes to Fcepsilon R imediated cytokine production but not mast cell degranulation [ J ]. Biol Chem,2008,283 (46) : 32110 - 8.
  • 10Mercier P, Lewis M J, Hau D D, et al. Structure, interactions, and dynamics of the RING domain from human TRAF6 [ J ]. Protein Sci ,2007,16(4) :602 - 14.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部